Novacell Innovations Biotechnology Company Limited, formerly known as Amoy Heron PSC Biomedicals Ltd., was established in 2014, and the company is committed to the large-scale cultivation of plant stem cells and the development and utilization of active natural products.

Novacell Innovations is located in the second phase of Xiamen Haicang Biomedical Industrial Park, with a laboratory, a quality control center, a R&D center, a plant stem cell bank, and a culture workshop. After years of unremitting efforts and countless experiments, we are now the industry's leading plant stem cell R&D and cultivation enterprises; It is a company that has developed an efficient plant stem cell factory production technology system. So far, the company has successfully isolated and cultivated stem cells of more than a dozen medicinal plants such as ginseng, agarwood, rose, honeysuckle, safflower, yew, dendrobium and so on.

At present, the self-developed ginseng tissue culture adventitious root suspension culture technology has entered the pilot stage, and its advantages over the traditional planting industry are: it does not occupy national land resources, the quality is controllable, the nutrients are stable, there are no pesticide residues, no heavy metals, no potential toxicity and other high-quality characteristics, which can be used as the development of food, cosmetics and other raw materials.

The purpose of Novacell Innovations is to deepen the health industry for the benefit of the people, and to benefit mankind on the basis of protecting land resources, which is a sustainable development project with a very promising prospect.